The Sam-Sam interaction between Ship2 and the EphA2 receptor: design and analysis of peptide inhibitors

Autor: Luciano Pirone, Emilia Pedone, Rosanna Palumbo, Roberta Iannitti, Concetta Di Natale, Daniela Marasco, Marilisa Leone, Flavia Anna Mercurio
Přispěvatelé: Mercurio, Flavia Anna, Di Natale, Concetta, Pirone, Luciano, Iannitti, Roberta, Marasco, Daniela, Pedone, Emilia Maria, Palumbo, Rosanna, Leone, Marilisa
Jazyk: angličtina
Rok vydání: 2017
Předmět:
Zdroj: Scientific Reports, Vol 7, Iss 1, Pp 1-11 (2017)
Scientific reports (Nature Publishing Group) 7 (2017). doi:10.1038/s41598-017-17684-5
info:cnr-pdr/source/autori:Mercurio, Flavia Anna; Di Natale, Concetta; Pirone, Luciano; Iannitti, Roberta; Marasco, Daniela; Pedone, Emilia Maria; Palumbo, Rosanna; Leone, Marilisa/titolo:The Sam-Sam interaction between Ship2 and the EphA2 receptor: design and analysis of peptide inhibitors/doi:10.1038%2Fs41598-017-17684-5/rivista:Scientific reports (Nature Publishing Group)/anno:2017/pagina_da:/pagina_a:/intervallo_pagine:/volume:7
Scientific Reports
ISSN: 2045-2322
DOI: 10.1038/s41598-017-17684-5
Popis: The lipid phosphatase Ship2 represents a drug discovery target for the treatment of different diseases, including cancer. Its C-terminal sterile alpha motif domain (Ship2-Sam) associates with the Sam domain from the EphA2 receptor (EphA2-Sam). This interaction is expected to mainly induce pro-oncogenic effects in cells therefore, inhibition of the Ship2-Sam/EphA2-Sam complex may represent an innovative route to discover anti-cancer therapeutics. In the present work, we designed and analyzed several peptide sequences encompassing the interaction interface of EphA2-Sam for Ship2-Sam. Peptide conformational analyses and interaction assays with Ship2-Sam conducted through diverse techniques (CD, NMR, SPR and MST), identified a positively charged penta-amino acid native motif in EphA2-Sam, that once repeated three times in tandem, binds Ship2-Sam. NMR experiments show that the peptide targets the negatively charged binding site of Ship2-Sam for EphA2-Sam. Preliminary in vitro cell-based assays indicate that -at 50 µM concentration- it induces necrosis of PC-3 prostate cancer cells with more cytotoxic effect on cancer cells than on normal dermal fibroblasts. This work represents a pioneering study that opens further opportunities for the development of inhibitors of the Ship2-Sam/EphA2-Sam complex for therapeutic applications.
Databáze: OpenAIRE
Nepřihlášeným uživatelům se plný text nezobrazuje